Download presentation
1
Radiographic evaluation
CT scan : Advantage Suggest the histologic type of the tumor The presence of fat and calcification within a tracheal mass : pathognomonic of a hamartoma Marked enhancement of a tracheal lesion after IV contrast : suggests carcinoid tumor Provide clues to the benign or malignant nature of a tracheal tumor
2
Radiographic evaluation
Features suggest : Benign lesion include intraluminal tumor with limited spread along the tracheal wall well-circumscribed lesion, smooth or lobulated appearance size usually < 2 cm Features suggest : Malignant tracheal lesion include irregular surface, extension over variable lengths of trachea extramural extension into the mediastinum lesions > 2 cm circumferential tracheal involvement enlarged mediastinal lymph nodes
3
Radiographic evaluation
CT scans : Disadvantage Unreliable for submucosal spread of disease Adenoid cystic carcinoma submucosal spread tend to grow slowly and push mediastinal structures away rather than invade them loss of fat planes between the tumor and mediastinal structures
4
Radiographic evaluation
MRI MRI offers some advantage over CT when vascular or cardiac invasion is suspected and to determine whether a lesion has a pedicle or broad-based attachment
5
Pulmonary Function Testing
PFT Can suggest upper airway obstruction Findings Severe reduction in PEFR and FEV1
6
Bronchoscopy Bronchoscopy represents the mainstay of diagnosis for tracheal tumors Rigid bronchoscopy Flexible bronchoscopy potentially hazardous for biopsy and manipulation of a tracheal tumor precipitate bleeding or total obstruction
7
Bronchoscopy Rigid bronchoscope
Pts with large proximal tracheal tumors Subtotal obstruction Ventilation can be maintained Used to dilate and core-out the malignant lesion providing stabilization of the airway Tumor bleeding : rarely a problem Bronchoscope used to apply pressure to the site Cautery or laser treatment
8
Treatment
9
Treatment Careful assessment of the overall situation
Coexistent medical disorders, esp. cardiopulmonary disease Pneumonia should be cleared Stabilized the airway rigid and flexible bronchoscopic techniques Important tracheal tumors once symptomatic can rapidly progress to critical airway obstruction
10
: typically asymptomatic, even with activities
Treatment Tracheal lumen ~ 8 mm Exertional dyspnea Worsens rapidly with any further decrease in diameter Tracheal lumen ≤ 5 mm Stridor present at rest Tracheal lumen > 10 mm : typically asymptomatic, even with activities
11
Primary Malignant tracheal tumors
12
Primary Malignant Tracheal Tumor
The majority of adult tracheal tumors are malignant The best therapy -> surgical excision with circumferential tracheal resection and primary end-to-end reconstruction Limitations to resectability include invasion of critical mediastinal structures involvement of such an extensive length of trachea that reconstruction would be impossible If metastatic is detected in superior mediastinal nodes -> combination chemoradiotherapy
13
Anesthetic Managment
14
Tracheostomy is unwarranted
Anesthetic Managment Before surgical resection of tracheal tumors Flexible and rigid bronchoscope techniques are used to stabilize the airway Tracheostomy is unwarranted Stomal placement may interfere subsequently with ideal positioning of the tracheal anastomosis Intubation
15
Surgical Management
16
Surgical Management Tracheal resection and primary reconstruction
Release maneuvers Subglottal resections Carinal resections
17
Tracheal Resection and Primary Reconstruction
A low-collar incision : cervical and upper 2/3 of intrathoracic trachea Tumors of the distal third of the trachea : right posterolateral thoracotomy Carina is involved : a median sternotomy A low-collar incision Provides access to the cervical and the upper 2/3 of the intrathoracic trachea Additional exposure : partial or complete sternotomy
18
Tracheal Resection and Primary Reconstruction
Benign tumors the dissection is kept immediately adjacent to the trachea no attempt to identify the RLNs Malignant tumors identification and preservation of the RLN if one RLN is involved with tumor sacrificed if sacrifice of both RLN requires concomitant tracheostomy subsequent vocal cord-lateralizing procedure paratracheal nodes are excised
19
Tracheal Resection and Primary Reconstruction
Resection margins should be assessed by intraoperative frozen section During resection -> prevent anastomotic tension ~ ½ of the trachea can be resected : primary anastomosis (but advanced patient age and prior mediastinal radiation) Before complete division and resection stay sutures at proximal and distal ends to assist alignment and gauge tension
20
A, A tumor of the upper trachea has been excised, and the proximal and distal ends of the trachea are mobilized. Interrupted simple sutures are placed with the knots on the outside. Ventilation is accomplished initially across the field with intubation of the distal airway. Subsequently, as the anastomosis nears completion, the endotracheal tube is advanced across the anastomosis B, A tumor of the distal trachea is excised, and ventilation is maintained by selective intubation of the left mainstem bronchus across the field. After suture placement, the endotracheal tube is advanced across the anastomosis and into the left mainstem bronchus. The completed anastomosis is wrapped with a pleural flap.
21
Tracheal Resection and Primary Reconstruction
Figure Guardian stitch is placed at the end of the operation to maintain neck flexion for the first postoperative week. To reduce tension on the anastomosis Cervical flexion is maintained with a heavy (No. 2) monofilament "guardian" stitch between the chin and the anterior chest wall Place for ~ 7 days usually removed after confirmation of anastomotic healing by bronchoscopy
22
Surgical Management Tracheal resection and primary reconstruction
Release maneuvers Subglottal resections Carinal resections
23
Release Maneuvers For resections involving the cervical trachea
Neck flexion and dissection along the anterior trachea in the neck and mediastinum An additional cm of tracheal length Suprathyroid laryngeal release Suprahyoid laryngeal release preferred lower incidence of swallowing complications postoperatively
24
Surgical Management Tracheal resection and primary reconstruction
Release maneuvers Subglottal resections Carinal resections
25
Subglottal Resections
Tumors involve the subglottal region require Prevent permanent RLN damage and vocal cord injury Excision of the anterior cricoid arch and the posterior cricoid plate leaving its perichondrium Primary thyrotracheal anastomosis usually within 1 cm of the inferior border of the vocal cords
26
Surgical Management Tracheal resection and primary reconstruction
Release maneuvers Subglottal resections Carinal resections
27
Carinal Resections Tumors involving the carinal
Need for tension-free anastomosis is critical Tumors involving > 4 cm of tracheal length : preclude resection
28
Carinal Resections The simplest technique for reconstruction
Involves approximating the medial walls of the right and left mainstem bronchi to fashion a new carina and then anastomosing to distal trachea Only with small tumors
29
Carinal Resections More commonly
the trachea is anastomosed end-to-end to one of the mainstem bronchi the other mainstem bronchus is sutured into the lateral wall of the trachea above the first anastomosis
30
Adjuvant radiotherapy
31
Adjuvant radiotherapy
Recommended for both SCCA and adenoid cystic CA Adenoid cystic CA are especially sensitive to radiation therapy Radiation therapy is usually commenced ~ 4 weeks after surgical resection use at least 60 Gy of radiation median survival was 24 months, and 5-year survival was 27%
32
Palliative Treatment of Unresectable
Malignant Tracheal Tumors
33
Therapeutic Bronchoscopy
Endoscopic procedures including Dilatation Mechanical débridement Laser vaporization PDT Cryotherapy Brachytherapy Stenting
34
Therapeutic Bronchoscopy
Extrinsic compression Only stenting can provide palliation Mechanical débridement, laser vaporization, PDT, cryotherapy, and brachytherapy are contraindicated For endotracheal lesions The optimal choice : depends on the individual tumor's characteristics Rigid bronchoscope can remove large tumor that obstruction by running the scope against the wall of the trachea and slicing off the tumor “coring-out” or mechanical débridement
35
Endoscopic technique
36
Therapeutic Bronchoscopy
Bleeding controlled compression by the rigid bronchoscope (+/- epinephrine-soaked sponges) Laser vaporization performed through a flexible bronchoscope combination with rigid bronchoscope the most frequently used laser Nd:YAG
37
Complications
38
Complications Regnard and colleagues : 4 factors that were significantly associated with the development of postoperative complications Increasing length of resection The need for laryngeal release Laryngotracheal or carinal resection Squamous cell histology
39
Complications Common problems after tracheal surgery include
Atelectasis Retained secretions Pneumonia Swallowing dysfunction with aspiration Wound infections Anastomotic dehiscence Tracheal-innominate or tracheal-pulmonary artery fistula
40
Complications Late complications include
Granulation tissue or stenosis at the anastomosis often be extracted endoscopic with a bx forcep Stenosis at the anastomosis Endoscopic techniques including dilation and T-tube placement
41
Summary
42
Summary Primary tracheal tumors are rare
In adults, most tumors are malignant More than 80% of malignant tracheal tumors are either SCCA or adenoid cystic CA Tracheal tumors are best managed by resection with end-to-end anastomosis Great care should be taken to avoid excessive tension on the anastomosis by limiting the extent of the resection cervical flexion appropriate release procedures
43
Summary Adjuvant radiotherapy is probably of benefit after resection of SCCA and adenoid cystic CA Particularly in those with positive resection margins Primary management for malignant tracheal tumors Medically unfit for an operation Unresectable tumors Metastatic disease
44
Summary Overall, the 5-year survival rate adenoid cystic CA 73% is much greater than for those with SCCA 47% Management for tumors involving the trachea secondarily is general palliative Aggressive tracheal resection for invasive thyroid carcinoma and bronchogenic carcinoma offers a chance for cure
45
Tumors of the Esophagus
46
Benign Esophageal Tumors and Cysts
Benign tumors are rare (< 1 %) Classified in two groups Mucosal Extramucosal (intramural) More useful classification: 60% of benign neoplasms are leiomyomas 20% are cysts 5% are polyps Others (< 2%)
47
Leiomyomas Most common benign tumor of the esophagus Intramural
Age years Male ~ Female 80% occur in the middle and lower third of the esophagus, they are rare in the cervical region Obstruction and regurgitation may occur in large lesions Bleeding is a more common symptom of the malignant form of the tumor : leiomyosarcoma
48
Esophageal Cysts Arise as diverticula of the embryonic foregut
¾ of this cyst present in childhood Over 60% are located along the right side of the esophagus Are often associated with vertebral anomalies (ex: spina bifida) 60% present in the first year of life with either respiratory or esophageal symptoms Cyst found in the upper third of the esophagus present in infancy while lower third lesions present later in childhood
49
Pedunculated Intraluminal Tumors (Polyps)
Benign polyps are rare Usually occur in older men and may cause intermittent dysphagia Are sometimes easily missed with barium swallow and esophagoscopy
50
Malignant Tumors of the Esophagus
51
Cancer
52
Malignant Tumors of the Esophagus
Usually are in advanced stages at the time of diagnosis (involving the muscular wall and extending into adjacent tissues) Alcohol consumption and cigarette smoking seem to be the most consistent risk factors
53
Malignant Tumors of the Esophagus
95% of all esophageal cancers is esophageal squamous cell carcinoma Male : female = 5:1 Squamous cell esophageal cancer occurs most often in the upper and midthoracic segments Squamous cell esophageal cancer occurs least frequently in the cervical esophagus and
54
Malignant Tumors of the Esophagus
Adenocarcinoma constitute approximate 8% of primary esophageal cancers Most often occur in the distal third of the esophagus in the 6th decade of life. Male to female ratio is 3:1 Patients with Barrett’s metaplasia are 40 times more likely to develop adenocarcinoma These tumors are aggressive as well
55
Clinical Presentation
Dysphagia is the presenting complaint in 80-90% of patients with esophageal carcinoma Early symptoms are sometimes nonspecific retrosternal discomfort or indigestion As the tumor enlarges, dysphagia becomes more progressive Later symptoms include weight loss, odynophagia, chest pain and hematemesis
56
Diagnosis Barium swallow Esophagoscopy Esophageal biopsy
Brushings for cytologic evaluation
57
Barium
58
Cancer : Apple Core Appearance
59
CT scan
60
Staging of Tumors Endoscopic ultrasound-to define the depth of invasion and presence of paraesophageal lymph nodes Chest x-ray ± abnormal findings CT scan (most widely used and now standard radiographic means of staging) Bronchoscopy for tumors which are proximal to the trachea
61
TMN Classification for Staging
The esophagus is first divided into four segments Cervical Upper thoracic Middle thoracic Lower
62
Current AJCC 2002 staging
63
Treatment Surgical resection is the standard treatment for early esophageal cancer ie Stages I, II and most cases of III 5-years survival rate % - stage I % - stage IIA % - stage IIB
64
Systemic Disorders that Cause Dysphagia
Stroke – present in up to 47% Amyotrophic Lateral Sclerosis Parkinson’s Disease Multiple Sclerosis Muscular Dystrophy Myasthenia Gravis
65
Autoimmune Disorders Systemic Sclerosis Systemic Lupus Erythematosis
Dermatomyosits Mixed Connective Tissue Disease Mucosal Pemphigoid, Epidermolysis Bulosa Sjogren’s Syndrome (xerostomia) Rheumatoid Arthritis (cricoarytenoid joint fixation)
66
Aging Dysphagia is present in 2% in age > 65 yr. Poor dentition
Loss of tongue connective tissue Increased pharyngeal transit time
67
Thank you for your attention
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.